Trial Profile

Exploratory randomized trial of evaluation for Tiotropium in lung cancer surgery

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 17 Mar 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tiotropium bromide (Primary) ; Beta 2 adrenergic receptor agonists; Cholinergic receptor antagonists
Indications Asthma; Chronic obstructive pulmonary disease; Postoperative complications
Focus Pharmacodynamics

Most Recent Events

11 May 2020 Planned End Date changed from 31 Oct 2019 to 29 Feb 2020.
11 Nov 2019 Planned End Date changed from 31 Mar 2018 to 31 Oct 2019.
10 May 2018 Status changed from suspended to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com